ESR1 and breast carcinoma: Does estrogen receptor (ER)–targeted 16α-18F-fluoro-17β-estradiol (FES) positron emission tomography (PET) computed tomography (CT) perform as well as current standard-of-care imaging (SOC) for staging locally advanced breast cancer or evaluating suspected recurrence?